Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
271M
-
Number of holders
-
128
-
Total shares
-
61.4M
-
Shares change
-
-632K
-
Total reported value, excl. options
-
$89.1M
-
Value change
-
-$836K
-
Put/Call ratio
-
0.21
-
Number of buys
-
43
-
Number of sells
-
-55
-
Price
-
$1.45
Significant Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q1 2024
128 filings reported holding PGEN - PRECIGEN, INC. - Common Stock as of Q1 2024.
PRECIGEN, INC. - Common Stock (PGEN) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.4M shares
of 271M outstanding shares and own 22.69% of the company stock.
Largest 10 shareholders include Patient Capital Management, LLC (17.5M shares), BlackRock Inc. (10.4M shares), VANGUARD GROUP INC (6.77M shares), GEODE CAPITAL MANAGEMENT, LLC (3.03M shares), STATE STREET CORP (2.83M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (2.09M shares), D. E. Shaw & Co., Inc. (1.78M shares), MILLENNIUM MANAGEMENT LLC (1.37M shares), JPMORGAN CHASE & CO (1.29M shares), and NORTHERN TRUST CORP (1.08M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.